Investors
Information Disclosure
-
NOTICE OF ANNUAL GENERAL MEETING2024.04.29
-
GENERAL MANDATES TO ISSUE AND BUY BACK SHARES; RE-ELECTION OF DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING2024.04.29
-
2023 ANNUAL REPORT2024.04.29
-
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS2024.04.29
-
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS2024.04.29
-
2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT2024.04.29
-
VOLUNTARY ANNOUNCEMENT - 52 RESEARCH RESULTS WILL BE PRESENTED AT 2024 ASCO ANNUAL MEETING2024.04.29
-
VOLUNTARY ANNOUNCEMENT - CATEGORY 1 INNOVATIVE DRUG “TQA3038 (siRNA)” COMPLETED PHASE I CLINICAL STUDY2024.04.25